Mr. Rajiv Nath is Managing Director of Hindustan Syringes & Medical Devices Ltd. He is President of All India Syringes & Needles Mfg. Association. (AISNMA).He is also the Founder and Forum Coordinator – Association of Indian Medical Device Industry (AiMeD) with over 350 Members nationwide whereby Medical Device Manufacturers of all types of technologies have been attracted nationwide on one Platform.

HMD created a niche for their disposable syringe “DISPOVAN” which is today the most popular brand in Syringe market in India

AiMeD is an Umbrella Association of Indian Manufacturers of Medical Devices covering all types of Medical Devices including consumables, disposables, equipment’s instruments, Implants, electronics and diagnostics. With a Primary Membership of over 400 Manufacturers and additionally of over 250 Associate Members representing the interest of over 1200 Manufacturers of Medical Devices to address the manufacturer’s problems. (www.aimedindia.com )

Position held:

• Managing Director of Hindustan Syringes & Medical Devices Ltd. (HMD)
• President of All India Syringes & Needles Mfg. Association. (AISNMA)
• Forum Coordinator of Association of Indian Medical Device Industry (AiMeD)
• Jt. Coordinator of Indian Medical Device Regulatory Review Group (IMDRRG)
• Jt. Coordinator of UdaiMeD (Forum of User – Developer – Academia – Industry – Medical Device Development interface with the Govt.)
• Board Member of Kalam Institute of Healthcare Technology
• Member National Medical Device Promotion Council
• Chairman IPC Committee on Medical Device Standard
• Chairman – Technical Committee – ICMED Certification by QCI
• Member of Expert Advisory Group (EAG) for Biomedical Device and Technology Development (BDTD) by Dept. of Science & Technology
• Member of Medical Devices – Expert Advisory Group to CDSCO for Regulation in India.
• He has widely travelled all over World to over 58 Countries and has attended various Meetings of WHO/ ICASA/SIGN / ISO / Stop TB
• Member of ISO / TC 84

Frans van den Boom PhD MBA, has more than 30 years leadership and management experience in professional international, multilingual and cross-cultural organizations, ranging from start-ups to mature organizations. He has unique experience in working with state and non-state actors in high, mid and low-income countries and working at the interfaces of political outreach, public policy development, resource mobilization, public health and health (services) research , planning and evaluation, and communication.

Dr. van den Boom has served as the Vice President, Country and Regional Programs and Executive Director Europe of the International AIDS Vaccine Initiative (IAVI) for 10 years, responsible for vaccine preparedness and community mobilization programs, the social and behavioral sciences program, and resource mobilization. He also served as Executive Director Policy, Planning and Evaluation at Qatar Foundation R&D (4 years), and Executive Director of the Dutch Top sector Life Sciences and Health(2 years). He joined the Human Vaccines Project in July 2018 as Executive Director Europe.

Dr Shirshendu Mukherjee, trained as a Medical Microbiologist brings with him more than 25 years of experience in academic institutes, Pharma companies and decade long experience in national, international philanthropic and Government funding agencies and has been instrumental in supporting the innovation ecosystem in India and beyond. Dr Mukherjee is currently the Mission Director of the Grand Challenges India, the flagship program of the partnership between the Department of Biotechnology, Ministry of Science & Technology, Government of India, the Bill & Melinda Gates Foundation and Wellcome Trust. This platform supports initiatives that could dramatically change the health and development landscape in India. He also heads the Intellectual Property (IP) & Technology Transfer (TT) and Communications Division in BIRAC. In addition to the above, Dr Mukherjee also leads the National Health Authority (NHA) (Ayushman Bharat – PM-JAY) Start-up Grand Challenges program from BIRAC. Dr. Mukherjee holds Ph.D. in Microbiology, Law graduate, leadership course form Said Business school university of Oxford and Global Health Leadership course from London School of Health & Tropical Medicine (LSHTM). Dr Mukherjee is also a Registered Technology Transfer Professional (RTTP) certified by the Alliance of Technology Transfer Professionals (ATTP) and is an Honorary Scientific Advisor to the Indian Patent Office. Dr Mukherjee is also the Country Ambassador in India for the Royal Society of Tropical Medicine & Hygiene (RSTMH). He is also the General Secretary of the Society for Technology Management professionals (STEM).

Dr. Arjun Dang is the Chief Executive Officer of the highly acclaimed for Quality , Dr Dangs Lab, situated in Delhi NCR. He completed his M.B.B.S and M.D in Pathology from Sri Ramachandra Medical College,Chennai post which he did a Clinical Fellowship in Liver Pathology from King’s College Hospital, London. DR Dang has worked as a Senior Resident in the department of Specialised Hematology (including flowcytometry) in Lady Hardinge Medical College and as a Research Fellow in department of histopathology in Indraprastha Apollo Hospital, New Delhi. At Dr Dangs Lab he plays a critical role in handling strategy & operations of the Lab.,enhancing patient care and training of staff. Dr Dang has worked extensively and is a renowned speaker in the areas of GI disorders and Allergy and has developed very specialized panels to aid diagnosis of these conditions .He also has a special interest in the field of oncology, he has done extensive work in the field of Triple Negative Breast carcinomas and also has publications on medullary carcinoma. Apart from this he has done various presentations related to primary adenocarcinoma of lung and dedifferentiated liposarcomas.
Dr. Dangs Lab was one of the first 3 labs to have started testing for H1N1 in 2009 and was amongst the first few private labs in New Delhi to be granted permission for testing for COVID 19. Dr. Arjun Dang has played a critical role in
1) Defining protocols related to infection control, training of staff, operations protocols, inventory management and analytical procedures. 2) Authenticating all molecular biology reports and maintaining the highest levels of quality.
3) Communication with ICMR and other govt. bodies regarding advisories and role of private laboratories for COVID 19 testing.
4) Setting up of India’s first drive thru centre for sample collection for Covid 19 patients
5) Dr. Dangs Lab, New Delhi was selected as the central lab for safety testing of COVAXIN (India’s first indigenous COVID19 vaccine ) for which the entire testing in phase 1 & 2 was performed at the central lab . The lab is currently also performing lab screening & safety for a number of covid19 vaccine manufacturers.
Dr. Dangs Lab was started in 1983 and has evolved to be known as one of the highly renowned diagnostic labs in the country known for its Quality as well as patient experience . The lab has received numerous national and international awards including the Excellence in Patient Care award by FICCI Healthcare Awards to recognize initiatives, innovations or new products / services that have led to improved customer satisfaction levels, or a better customer experience. Known for its advanced and high quality diagnostic services, Dr Dangs Lab is a standalone state-of-the-art facility ,performing a wide array of tests in Microbiology, Biochemistry, Haematology including Flowcytometry, Molecular biology, Immunology, Histopathology, Cytology amongst others . Dr Dangs Lab works on the four pillars of unmatched quality, top technology, trained professionals and personalised care.Dr Dangs Lab is accredited by National Accreditation Board for Testing & Calibration of Laboratories NABL as per ISO 15189:2012. It was one of the first labs in the country to receive ISO-9001 certification and has been accredited by NABL since 2001 . The lab was the first one in India to introduce Bacteriophage sensitivity testing last year in october .Dr Dangs Lab is currently engaged as a preferred lab partner with leading vaccine players conducting regulated trials. Besides these, several academic studies are running in partnership with leading academicians and clinicians, including those on nutritional deficiencies to provide advanced and accurate laboratory testing services.